Global Aging And Personalized Medicine Will Open Therapeutic Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 14 Analysts
Published
09 Jun 25
Updated
15 Aug 25
AnalystHighTarget's Fair Value
JP¥2,200.00
24.0% undervalued intrinsic discount15 Aug
JP¥1,671.00
1Y
-2.6%7D
3.4%